Medical/Pharmaceuticals
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease
* CBL-514 is the first and only drug to receive both Orphan Drug Designation and Fast Track designation for Dercum's disease treatment. NEW TAIPEI CITY, March 4, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan D...
2024-03-04 16:22
1226
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
FORT LEE, N.J., March 2, 2024 /PRNewswire/ -- Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr.Rahu...
2024-03-02 10:26
2884
The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China
NANYANG, China, March 2, 2024 /PRNewswire/ -- Co-hosted by the Nanyang Chinese Medicine Development Bureau, the China Association of Chinese Medicine (CACM) and the China Association of Traditional Chinese Medicine (CATCM), the Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Dev...
2024-03-02 05:10
3165
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
* Kinnate has entered into an Asset Purchase Agreement (the "APA") with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets. * The transaction is in furtherance of Kinnate's previously announced pursuit of strategic alternatives. * This acquisition is ...
2024-03-01 21:35
3641
Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia
ROCKVILLE, Md. and SUZHOU, China, March 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2024-03-01 08:00
2654
Metabolon Unveils New Integrated Bioinformatics Platform
Metabolon's cutting-edge bioinformatics platform and unique knowledge base will enable customers to leverage the company's extensive biochemistry experience MORRISVILLE, N.C., Feb. 29, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide var...
2024-02-29 20:58
1554
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Collaboration will harness Medidata Electronic Clinical Outcome Assessment
(eCOA) for remote patient engagement and real-time data capture
SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Medidata
2024-02-29 17:40
1478
The Adecco Group: Q4 & FULL YEAR 2023 RESULTS
AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange ZURICH, Feb. 29, 2024 /PRNewswire/ -- Q4 & FULL YEAR 2023 RESULTS Continued growth and significant share gains amid tougher markets, strong profitability improvement Q4 HIGHLIGHTS * Revenues +1% yoy, led by Adec...
2024-02-29 13:45
1383
Nin Jiom, Modern Chinese Medicine Pioneer, to Launch NMN Supplement for Healthy Ageing
SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Nin Jiom
2024-02-29 11:00
1448
MGI Tech & Juntendo University: Changing the Landscape and Unlocking Answers for Patients with Rare Diseases
TOKYO, Feb. 29, 2024 /PRNewswire/ -- Rare diseases have historically been overlooked because they affect relatively few people. While they are identified and addressed differently around the world, there are over known 6,000 rare diseases – characterized by a wide range of disorders and symptoms...
2024-02-29 09:00
1929
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease
SKY-0515 is a small molecule RNA splicing modifier developed through the company's novel SKYSTAR® platform. Having successfully advanced through single asending dose, SKY-0515 is advancing into the Multiple Ascending Dose portion of its phase 1 study. Huntington's disease is a fatal neurological ...
2024-02-28 21:32
1202
RRD International is now RRD Biopharma Development
RRD Biopharma Development is the dynamic new brand of RRD International. Launched to reflect the company's unique approach to drug development through its successful Product Development Team model. ROCKVILLE, Md., Feb. 28, 2024 /PRNewswire/ -- RRD International has announced today that it launch...
2024-02-28 21:00
1302
First product based on LTS Sorrel™ wearable drug delivery platform launched in the US
ANDERNACH, Germany, Feb. 28, 2024 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, announced today that its customer Coherus BioSciences, Inc ("Coherus") has launched its UDENYCA® on-body injector (OBI) utilizing the LTS Sorrel™ wearable drug d...
2024-02-28 20:00
2037
The 20th International Congress on Luobing Theory Held in Shijiazhuang
SHIJIAZHUANG, China, Feb. 28, 2024 /PRNewswire/ -- On February 24, the 20th International Congress on Luobing Theory was held inShijiazhuang, which consisted of 1 main forum and 12 sub-forums. Approximately 20 academicians from both Chinese Academy of Sciences and Chinese Academy of Engineering, ...
2024-02-28 09:37
1151
Vieworks Unveils Cutting-Edge X-ray Imaging Solutions at ECR 2024
ANYANG, South Korea, Feb. 28, 2024 /PRNewswire/ -- Vieworks, a leading provider of medical and industrial X-ray imaging solutions, is gearing up to showcase its innovative lineup at the European Congress of Radiology (ECR) 2024, scheduled fromFebruary 28 to March 3 in Vienna, Austria. Vieworks wi...
2024-02-28 04:01
1112
BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions
ADELAIDE, South Australia, and PERTH, Western Australia, Feb. 27, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide in...
2024-02-28 02:30
1093
Kakao Brain Unveils Labeler Project Exclusively for Medical Image preliminary report
* A Labeler project capable of diagnosing specific diseases from image readings written in natural language. * Capable of identifying a total of 13 diseases with high incidence rates and importance, including fractures, pleural lesions, and pneumothorax. * Recorded an accuracy of 90.39%, hig...
2024-02-27 21:00
1012
New Models of PENTAX Medical i20c Video Endoscope Series Obtain CE Marks
TOKYO, Feb. 27, 2024 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group,
have obtained CE marks for new models of PENTAX Medical i20c Video Endoscope
Series - PENTAX Medical Video Colonoscope EC34-i20c, PENTAX Medical Video Upper
GI Scope EG27-i20c and R/L Knob Adaptor OE-B17.
2024-02-27 17:00
1060
Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China
SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- On February 26, 2024, Illumina Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, announced thatJenny Zheng joins Illumina as Senior Vice President and General Manager ofGreater China, and a member of the global executive ma...
2024-02-27 16:09
1105
Amaris B. Clinic's Research Reveals Dynamic Skin Care Priorities Across Age Groups in Singapore
The data analysis concluded that the need for personalised solutions should exceed conventional beauty standards, prioritising holistic wellness and skin vitality. SINGAPORE, Feb. 27, 2024 /PRNewswire/ -- Amaris B Clinic, an established medical aesthetic, sculpting, and fitness clinic inSingapor...
2024-02-27 15:21
1190
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
2999
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2966
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2965
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
2024-04-28 09:39
2848